Effects of three N-(carboxyanilinomethyl) derivatives of p-isopropoxyphenylsuccinimide on the anticonvulsant action of carbamazepine, phenobarbital, phenytoin and valproate in the mouse maximal electroshock-induced seizure model

European Journal of Pharmacology

Volumn 648, Issue 1-3, 2010, Pages 74-79

  Luszczki, Jarogniew J ^a,b   Cioczek, Janina D ^a   Kocharov, Sergey L ^c   Andres Mach, Marta ^b   Kominek, Mateusz ^a   Zolkowska, Dorota ^d  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

^c INSTITUTE OF ORGANIC CHEMISTRY   (Armenia)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antiepileptic drug; Maximal electroshock induced seizure; Pharmacokinetic pharmacodynamic interaction; Succinimide derivative

Indexed keywords

CARBAMAZEPINE; N (2 CARBOXYANILINOMETHYL) 4 ISOPROPOXYPHENYLSUCCINIMDE; N (3 CARBOXYANILINOMETHYL) 4 ISOPROPOXYPHENYLSUCCINIMDE; N (4 CARBOXYANILINOMETHYL) 4 ISOPROPOXYPHENYLSUCCINIMDE; PHENOBARBITAL; PHENYTOIN; SUCCINIMIDE DERIVATIVE; UNCLASSIFIED DRUG; VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG BRAIN LEVEL; DRUG EFFICACY; DRUG MECHANISM; ELECTRIC SHOCK; FLUORESCENCE POLARIZATION IMMUNOASSAY; GRIP STRENGTH; LONG TERM MEMORY; MALE; MOTOR COORDINATION; MOTOR PERFORMANCE; MOUSE; MUSCLE STRENGTH; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; SEIZURE;

ANILINE COMPOUNDS; ANIMALS; ANTICONVULSANTS; BEHAVIOR, ANIMAL; BRAIN; CARBAMAZEPINE; DISEASE MODELS, ANIMAL; DRUG INTERACTIONS; ELECTROSHOCK; MALE; MEMORY; MICE; MOTOR ACTIVITY; MUSCLE STRENGTH; MUSCLE, SKELETAL; PHENOBARBITAL; PHENYTOIN; SEIZURES; SUCCINIMIDES; VALPROIC ACID;

EID: 77957754664     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.08.017     Document Type: Article

References (21)

1. Beghi E., Gatti G., Tonini C., Ben-Menachem E., Chadwick D.W., Nikanorova M., Gromov S.A., Smith P.E., Specchio L.M., Perucca E. Adjunctive therapy versus alternative monotherapy in patients with partial epilepsy failing on a single drug: a multicentre, randomised, pragmatic controlled trial. Epilepsy Res. 2003, 57:1-13. BASE Study Group.
2. Boissier J.R., Tardy J., Diverres J.C. A simple novel method to explore tranquilizer activity: the chimney test (in French). Med. Exp. Basel 1960, 3:81-84.
3. Borowicz K.K., Gasior M., Kleinrok Z., Czuczwar S.J. Influence of isradipine, niguldipine and dantrolene on the anticonvulsive action of conventional antiepileptics in mice. Eur. J. Pharmacol. 1997, 323:45-51.
4. Cadart M., Marchand S., Pariat C., Bouquet S., Couet W. Ignoring pharmacokinetics may lead to isoboles misinterpretation: illustration with the norfloxacin-theophylline convulsant interaction in rats. Pharm. Res. 2002, 19:209-214.
5. Kaminski K., Obniska J. Synthesis and anticonvulsant properties of new 1-(2-pyridinyl)-3-substituted pyrrolidine-2, 5-dione derivatives. Acta Pol. Pharm. 2008, 65:457-465.
6. Kwan P., Brodie M.J. Early identification of refractory epilepsy. N. Engl. J. Med. 2000, 342:314-319.
7. Kwan P., Brodie M.J. Epilepsy after the first drug fails: substitution or addition?. Seizure 2000, 9:464-468.
8. Lange J., Rump S., Galecka E., Ilczuk I., Lechowska-Postek M., Rabsztyn T. Synthesis and properties of new cyclic derivatives of succinic acid with anticonvulsant activity. Pharmazie 1977, 32:82-84.
9. Litchfield J.T., Wilcoxon F. A simplified method of evaluating dose-effect experiments. J. Pharmacol. Exp. Ther. 1949, 96:99-113.
10. Löscher W., Fassbender C.P., Nolting B. The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models. Epilepsy Res. 1991, 8:79-94.
11. Luszczki J.J., Swiader M., Czuczwar M., Kis J., Czuczwar S.J. Interactions of tiagabine with some antiepileptics in the maximal electroshock in mice. Pharmacol. Biochem. Behav. 2003, 75:319-327.
12. Luszczki J.J., Wojcik-Cwikla J., Andres M.M., Czuczwar S.J. Pharmacological and behavioral characteristics of interactions between vigabatrin and conventional antiepileptic drugs in pentylenetetrazole-induced seizures in mice: an isobolographic analysis. Neuropsychopharmacology 2005, 30:958-973.
13. Luszczki J.J., Antkiewicz-Michaluk L., Czuczwar S.J. Isobolographic analysis of interactions between 1-methyl-1, 2, 3, 4-tetrahydroisoquinoline and four conventional antiepileptic drugs in the mouse maximal electroshock-induced seizure model. Eur. J. Pharmacol. 2009, 602:298-305.
14. Luszczki J.J., Kocharov S.L., Czuczwar S.J. N-(anilinomethyl)-p-isopropoxyphenyl-succinimide potentiates the anticonvulsant action of phenobarbital and valproate in the mouse maximal electroshock-induced seizure model. Neurosci. Res. 2009, 64:267-272.
15. Luszczki J.J., Kocharov S.L., Czuczwar S.J. Effect of p-isopropoxyphenylsuccinimide monohydrate on the anticonvulsant action of carbamazepine, phenobarbital, phenytoin and valproate in the mouse maximal electroshock-induced seizure model. Pharmacol. Rep. 2010, 62:194-202.
16. Meyer O.A., Tilson H.A., Byrd W.C., Riley M.T. A method for the routine assessment of fore- and hindlimb grip strength of rats and mice. Neurobehav. Toxicol. 1979, 1:233-236.
17. Stables J.P., Kupferberg H.J. The NIH Anticonvulsant Drug Development (ADD) Program: preclinical anticonvulsant screening project. Molecular and Cellular Targets for Anti-epileptic Drugs 1997, 191-198. John Libbey, London. G. Avanzini, G. Regesta, P. Tanganelli, M. Avoli (Eds.).
18. Venault P., Chapouthier G., de Carvalho L.P., Simiand J., Morre M., Dodd R.H., Rossier J. Benzodiazepine impairs and beta-carboline enhances performance in learning and memory tasks. Nature 1986, 321:864-866.
19. White H.S. Preclinical development of antiepileptic drugs: past, present, and future directions. Epilepsia 2003, 44:2-8.
20. White H.S., Woodhead J.H., Wilcox K.S., Stables J.P., Kupferberg H.J., Wolf H.H. Discovery and preclinical development of antiepileptic drugs. Antiepileptic Drugs 2002, 36-48. Lippincott Williams & Wilkins, Philadelphia. fifth ed. R.H. Levy, R.H. Mattson, B.S. Meldrum, E. Perucca (Eds.).
21. Zejc A., Obniska J., Wilimowski M., Rutkowska M., Witkowska M., Barczynska J., Kedzierska-Gozdzik L., Wojewodzki W., Orzechowska-Juzwenko K., Plawiak T. Synthesis and anticonvulsant properties of some arylsuccinate methylpyridylimides. Pol. J. Pharmacol. Pharm. 1990, 42:69-77.